脳血管攣縮の実験的研究 : Oxy Hb, FDP, 赤血球膜分解産物の攣縮能と治療法の開発
スポンサーリンク
概要
- 論文の詳細を見る
In the previous studies, oxyhemoglobin or its allied polypeptides was found to be one of the most important causal factors of vasospasms. Haptoglobin has been found to be effective in releasing vasospasms in experimental models, but its beneficial effects in clinical cases were rather inconsistent. This is a report of our further studies, to find new spasmogenic substances in addition to Hb and to make the effects of Hp therapy more consistent and reliable. In in vitro models vasoactivity of test substances was checked using a spirally cut strip of canine basilar artery. In the in vivo system, vasospasms were examined by cerebral angiography after the injection of the vasoactive substances directly into the chiasmatic cistern. Breakdown products of the erythrocyte-membrane were found to be vasoactive in vitro. Its activity was markedly decreased after the procedure of lipid extraction and was partially blocked by the addition of serum albumin. However, less contractile response of the ghost breakdown products was observed in the in vivo experiments. Fibrin degradation products (FDP), especially low molecular weight FDP (LMW FDP) demonstrated strong vasoactivity. Vasoactivity of FDP could be blocked by diphenhydramine. It was also found that FDP potentiated the vasocontractile action of Hb, and also augmented contraction induced by an aged erythrocyte-CSF mixture. When FDP was injected into the basal cistern in combination with hemoglobin, the marked vasospasms of a prolonged nature were demonstrated in the repeated angiograms. The degree of vasospasm thus produced was much greater than that induced by a single injection of hemoglobin. This vasospasm could be effectively released by the topical use of diphenhydramine and Hp. Gabexate mesilate (FOY) was moderately effective in releasing vasospasms even when it was administered intravenously. Systemic administration of gabexate mesilate and diphenhydramine was also effective for prolonged vasospasms induced by cisternal injection of autogeneous arterial blood in some cases. In the other cases additional topical application of Hp and diphenhydramine after removal of the subarachnoid hematoma by the transclival approach might be needed to release the vasospasm effectively.
- 日本脳神経外科学会の論文
- 1980-03-15
著者
関連論文
- 高齢者の腰部脊柱管狭窄症に対する片側進入顕微鏡下開窓術の手術成績 : 前期および後期高齢者間での比較
- 頭蓋内圧環境と髄液循環動態よりとらえた水無脳症(Hydranencephaly)の特徴
- 出生前診断が有用であった Epignathus の1治験例
- Down 症候群に合併した環椎軸椎脱臼1治療例
- 小児 astrocytoma 40例の臨床病理学的検討 : 免疫組織化学的所見 (MIB-1 染色とp53染色)と予後の関係
- コミュニケーションスキル
- 内頚動脈血流遮断試験 (balloon occlusion test) 時の脳循環動態 : 局所脳血流量, mean stump pressure ならびに脳血管写所見の関連と脳虚血性神経症状発現の閾値について
- Chiari I型奇形 : アンケート結果のまとめ(キアリ奇形, 脊髄空洞症)
- 脊髄硬膜動静脈瘻を伴わない Foix-Alajouanine 症候群の手術
- 神経管形成モデル細胞における葉酸のWntシグナル伝達系(第23回日本脊髄外科学会推薦演題抄録)
- 高齢者頸椎症に対する頸椎前方手術の臨床的検討
- 治療に難渋した乳児後頭蓋窩AVFの1例
- 脳神経外科診療におけるDPCの結果指標の検討
- 乳児もやもや病の診断と外科的治療
- 重症小脳梗塞の外科的治療-脳室ドレナージか梗塞巣切除術か-
- 前脊髄動脈を供給動脈とする延髄腹側部AVMに対する手術
- 第3脳室内Ependymal Cystに対する手術
- 第3脳室腫瘍に対する anterior transcallosal approach(経大脳半球間裂アプローチ)
- 小脳脳石症の1例
- 脳血管写上 early venous drainage と caput medusae 様の異常血管像を呈した小脳橋角部神経鞘腫
- 脳血管攣縮の実験的研究 : Oxy Hb, FDP, 赤血球膜分解産物の攣縮能と治療法の開発
- 脳血管攣縮--実験的研究を中心として (脳梗塞と脳出血)
- 頸髄動静脈奇形と動脈瘤合併の一例
- 一相性低用量経口避妊剤服用中に発症した静脈洞血栓症の1例
- Medulloblastoma with Extensive Nodularity : 乳児易出血例
- 胸椎硬膜外に発生した良性間葉腫の 1 例
- 頭蓋骨内髄膜腫の1例
- How to treat these lesions
- 学会における日英同時通訳の役割
- 脳・脊髄病変--解剖学的部位と代表的症候・神経学的所見 (イラストでわかる脳神経外科手術と術式別ケア)
- 米国の脊椎脊髄手術に関連する医療過誤・医療訴訟問題の現状
- 頚椎前方手術のまれな合併症と患者への説明
- ミケランジェロの隠し神経解剖図
- A case of sarcoidosis initially presented Mikulicz syndrome, then complicated with hydrocephalus during the following steroid therapy
- 感染性硬膜下血腫の1乳児例